Scarica l'app Stockscreener
3.90
0.13%
-0.02
Lixte Biotechnology Holdings Inc Azioni (LIXT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.75%
0.9669
|
1.0259 | 1.0242 | 1.67 | 1.3701 |
| Interest Income/Expense |
29.17%
0.00719
|
0.0101 | 0.000279 | 0.00195 | 0.00386 |
| Operating Income/Loss |
5.75%
-0.9669
|
-1.0259 | -1.0242 | -1.67 | -1.3701 |
| Income/Loss From Continuing Operations Before Tax |
5.90%
-0.9713
|
-1.0323 | -1.0188 | -1.6684 | -1.3677 |
| Income/Loss From Continuing Operations After Tax |
5.90%
-0.9713
|
-1.0323 | -1.0188 | -1.6684 | -1.3677 |
|
Net Income/Loss
|
5.90%
-0.9713
|
-1.0323 | -1.0188 | -1.6684 | -1.3677 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,902%
2.2493
|
0.1124 | 2.0749 | 1.666 | 16.65 |
| Diluted Average Shares |
1,902%
2.2493
|
0.1124 | 2.0749 | 1.666 | -0.000477 |
| Basic Earnings Per Share |
4.88%
-0.43
|
-0.41 | -0.49 | -1.00 | -0.08 |
| Diluted Earnings Per Share |
4.88%
-0.43
|
-0.41 | -0.49 | -1.00 | -0.82 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):